Researchers have not definitively established causation, but several factors likely contribute
Nausea increases with dose, as expected, but the slope is gentler than with semaglutide
However, powder forms sold outside regulated trials have no validated stability data, no approved reconstitution method, and carry serious, unpredictable health risks
Each week, the dose will go up until it reaches a maximum of 15 mg
If you experience any suspected side effects, report them to the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk) to help monitor medication safety
One number that circulates: "21 days at room temperature for retatrutide." That figure refers to the factory-filled pen formulation, not a pharmacist-compounded vial